B. Wallin

975 total citations
22 papers, 766 citations indexed

About

B. Wallin is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, B. Wallin has authored 22 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Surgery. Recurrent topics in B. Wallin's work include Pharmacological Effects and Toxicity Studies (6 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (5 papers). B. Wallin is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (5 papers). B. Wallin collaborates with scholars based in United States, Mexico and Germany. B. Wallin's co-authors include Terri Sebree, Randall J. Mack, Kenneth B. Kashkin, Dan Zimbroff, David G. Daniel, John M. Kane, Carol A. Tamminga, Patricia J. Wozniak, Wei Du and Thomas A. Witkowski and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Psychiatry and Neurology.

In The Last Decade

B. Wallin

22 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wallin United States 11 288 266 166 134 132 22 766
M. Giguère Canada 9 124 0.4× 36 0.1× 66 0.4× 88 0.7× 54 0.4× 14 679
Roland Jimenez United States 15 245 0.9× 140 0.5× 369 2.2× 112 0.8× 28 0.2× 45 1.1k
Ko Kobayashi Japan 16 409 1.4× 252 0.9× 47 0.3× 97 0.7× 46 0.3× 88 941
Mustafa F. Usta United States 18 1.4k 4.7× 284 1.1× 71 0.4× 209 1.6× 21 0.2× 28 1.7k
Péter Takács Hungary 12 108 0.4× 27 0.1× 22 0.1× 75 0.6× 17 0.1× 23 480
Stefan Löb Germany 15 203 0.7× 186 0.7× 20 0.1× 223 1.7× 309 2.3× 35 1.2k
Richard Spark United States 11 256 0.9× 57 0.2× 100 0.6× 138 1.0× 47 0.4× 15 659
Xin Zhong China 14 62 0.2× 237 0.9× 9 0.1× 118 0.9× 391 3.0× 36 911
Madhu Chauhan United States 19 87 0.3× 107 0.4× 66 0.4× 237 1.8× 18 0.1× 44 777
Khalil G. Saikali United States 16 230 0.8× 53 0.2× 29 0.2× 253 1.9× 57 0.4× 35 1.5k

Countries citing papers authored by B. Wallin

Since Specialization
Citations

This map shows the geographic impact of B. Wallin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wallin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wallin more than expected).

Fields of papers citing papers by B. Wallin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wallin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wallin. The network helps show where B. Wallin may publish in the future.

Co-authorship network of co-authors of B. Wallin

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wallin. A scholar is included among the top collaborators of B. Wallin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wallin. B. Wallin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Viscusi, Eugene R., Thomas A. Witkowski, K. Gabriel, et al.. (2006). Alvimopan, a perpherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery. Surgical Endoscopy. 20(3). 537–537. 1 indexed citations
3.
Viscusi, Eugene R., Scott Goldstein, Thomas A. Witkowski, et al.. (2005). Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery. Surgical Endoscopy. 20(1). 64–70. 149 indexed citations
4.
Foss, Joseph, et al.. (2005). Alvimopan (entereg?), a novel opioid antagonist, achieves active systemic concentrations. Clinical Pharmacology & Therapeutics. 77(2). P74–P74. 10 indexed citations
5.
6.
Paulson, Daryl, Daniel Kennedy, Richard Donovick, et al.. (2004). Novel therapeutic agents. Journal of Pain. 5(3). S57–S57. 3 indexed citations
7.
Zimbroff, Dan, John M. Kane, Carol A. Tamminga, et al.. (1997). Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. American Journal of Psychiatry. 154(6). 782–791. 226 indexed citations
8.
Willmore, L. James, Vincent Shu, & B. Wallin. (1996). Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology. 46(1). 49–53. 21 indexed citations
9.
Kudelka, Andrzej P., Damrong Tresukosol, Creighton L. Edwards, et al.. (1996). Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.. Journal of Clinical Oncology. 14(5). 1552–1557. 208 indexed citations
10.
Daniel, Davey B., et al.. (1996). Two open-label, long-term safety studies of sertindole. European Neuropsychopharmacology. 6. 61–62. 6 indexed citations
11.
Bark, Nigel, Randall J. Mack, Jeanne V. Zborowski, et al.. (1996). Efficacy and safety of three doses of sertindole and haloperidol in schizophrenic patients. Biological Psychiatry. 39(7). 597–597. 2 indexed citations
12.
Mack, Randall J., et al.. (1996). Efficacy, safety, and dose response of three doses of sertindole and three doses of haldol in schizophrenic patients. Schizophrenia Research. 18(2-3). 133–134. 17 indexed citations
13.
Tamminga, C.A., Randall J. Mack, Jeanne V. Zborowski, et al.. (1996). Efficacy and safety of three doses of sertindole and haldol in schizophrenic patients. European Neuropsychopharmacology. 6. 61–61. 3 indexed citations
14.
Bowden, Charles L., J.R. Calabrese, B. Wallin, et al.. (1995). Illness characteristics of patients in clinical drug studies of mania.. PubMed. 31(1). 103–9. 20 indexed citations
15.
Targum, Steven D., et al.. (1995). P-4-71 Efficacy and safety of sertindole in two double-blind, placebo-controlled trials of schizophrenic patients. European Neuropsychopharmacology. 5(3). 348–349. 42 indexed citations
16.
Zborowski, Jeanne V., J O'Neil, Kristina A. Giles, et al.. (1995). Efficacy and safety of sertindole in a trial of schizophrenic patients. Biological Psychiatry. 37(9). 661–662. 15 indexed citations
17.
Daniel, Davey B., et al.. (1995). P-4-70 Two open-label, long-term safety studies of sertindole. European Neuropsychopharmacology. 5(3). 348–348. 2 indexed citations
18.
Kudelka, A P, B. Wallin, M Hord, et al.. (1993). A phase II study of topotecan administered intravenously as 5 daily infusions every 21 days to women with refractory epithelial ovarian carcinoma. European Journal of Cancer. 29. S132–S132. 7 indexed citations
19.
Jansson, Kjell & B. Wallin. (1991). Developments in transport policy: deregulation of public transport in Sweden. Journal of transport economics and policy. 25(1). 5 indexed citations
20.
Jansson, Kjell & B. Wallin. (1991). DEREGULATION OF PUBLIC TRANSPORT IN SWEDEN. Journal of transport economics and policy. 25(1). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Giguère Breakdown of academic impact, for papers by Roland Jimenez Breakdown of academic impact, for papers by Ko Kobayashi Breakdown of academic impact, for papers by Mustafa F. Usta Breakdown of academic impact, for papers by Péter Takács Breakdown of academic impact, for papers by Stefan Löb Breakdown of academic impact, for papers by Richard Spark Breakdown of academic impact, for papers by Xin Zhong Breakdown of academic impact, for papers by Madhu Chauhan Breakdown of academic impact, for papers by Khalil G. Saikali
Rankless by CCL
2026